St. Jude Medical COMPANY OVERVIEW FORTUNE St. Jude Medical is a global medical device manufacturer dedicated to transforming the treatment of some of the world’s most expensive epidemic diseases. The company does this by developing cost-effective medical technologies that save and improve the lives of patients around the world. Headquartered in St. Paul, Minn., St. Jude Medical employs approximately 16,000 people worldwide and has four major clinical focus areas that include cardiac rhythm management, atrial fibrillation, cardiovascular and neuromodulation. COMPANY FACTS 2014 Revenue: Global Headquarters: Revenue (in millions) $5.622 billion St. Paul, Minn. Stock Exchange: New York Stock Exchange (NYSE) / ticker STJ 500 COMPANY FY 12 $ 5,503 FY 13 $ 5,501 FY 14 $ 5,622 Founded: 1976 in St. Paul, Minn. Global Reach: Operations and manufacturing facilities worldwide, with products sold in more than 100 countries Employees: Approximately 16,000 2014 HIGHLIGHTS ¢¢ ¢¢ ¢¢ ¢¢ ¢¢ 12% OF REVENUE IS INVESTED IN RESEARCH & DEVELOPMENT Delivered on our commitment to improving patient outcomes and reducing the economic burden of conditions such as heart failure, atrial fibrillation and chronic pain. Net sales increased 4 percent over the prior year on a constant currency basis. Acquired CardioMEMS, Inc., a privately held developer of the CardioMEMS™ HF System, the first and only FDA-approved heart failure (HF) monitoring device that has been proven to significantly reduce HF hospital admissions when used by physicians to manage heart failure. Acquired NeuroTherm, Inc., a privately held manufacturer and global leader in the treatment of spinal pain using radiofrequency ablation. Increased our quarterly dividend by 8 percent. 2014 Sales by Geography 47% U.S. 53% International INNOVATION AT ST. JUDE MEDICAL We believe that investing in purposeful innovation is instrumental in our success. We are uniquely positioned for long-term growth driven by our vision to address expensive epidemic diseases with solutions that improve lives and reduce the economic burden on health care systems worldwide. Atrial Fibrillation (AF): St. Jude Medical is a pioneer and a leader in the global AF market, which is estimated at more than $2.9 billion. The company offers the industry’s broadest product portfolio for the electrophysiology (EP) lab, aiding physicians in the diagnosis and treatment of cardiac arrhythmias. Cardiac Rhythm Management (CRM): We estimate that the worldwide CRM market is approximately $10 billion in size. With the industry’s first quadripolar pacing system featuring four pacing electrodes, St. Jude Medical is providing physicians with innovative technology that is able to reduce common complications seen with traditional bipolar leads when delivering resynchronization therapy to heart failure patients. Neuromodulation: St. Jude Medical is a strong contributor in the $2 billion neuromodulation market. We are working to bring innovative products to underpenetrated markets of spinal cord stimulation (SCS) and deep brain stimulation (DBS) in order to improve patient care. During 2014, St. Jude Medical acquired NeuroTherm, Inc., a privately held manufacturer and global leader in the treatment of spinal pain using radiofrequency ablation. Cardiovascular: St. Jude Medical participates in the vascular and structural heart markets that when combined total more than $5 billion. We have strong franchises in heart valve replacement, fractional flow reserve (FFR) and optical coherence tomography (OCT) intravascular imaging systems, vascular closure and left atrial appendage occlusion. In 2014, St. Jude Medical acquired CardioMEMS, Inc., to introduce the first and only FDA-approved heart failure monitor proven to significantly reduce heart failure hospital admissions and improve quality of life in NYHA Class III patients. 2014 Net Sales by Product Category 24% 18% 8% 50% 18% Atrial Fibrillation 50% Cardiac Rhythm Management 8% Neuromodulation 24% Cardiovascular Rx Only Brief Summary: Prior to using these devices, please review the Instructions for Use for a complete listing of indications, contraindications, warnings, precautions, potential adverse events and directions for use. Unless otherwise noted, ™ indicates that the name is a trademark of, or licensed to, St. Jude Medical or one of its subsidiaries. ST. JUDE MEDICAL and the nine-squares symbol are trademarks and service marks of St. Jude Medical, Inc. and its related companies. © 2015 St. Jude Medical, Inc. All Rights Reserved. St. Jude Medical Inc. Global Headquarters One St. Jude Medical Drive St. Paul, MN 55117 USA T +1 651 756 2000| F +1 651 756 3301 Investor Contact J.C. Weigelt T +1 651 756 4347 SJM-COR-0115-0053(1) | Item approved for global use. SJM.com | follow us on Twitter @ StJudeMedicalIR
© Copyright 2024